{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:55:23Z","timestamp":1790610923473,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014452","name":"College of Medicine, University of Cincinnati","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007623","name":"School of Medicine, Emory University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ijrobp.2020.10.025","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T19:13:44Z","timestamp":1603566824000},"page":"1040-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity"],"prefix":"10.1016","volume":"109","author":[{"given":"Daniel A.","family":"Pomeranz Krummel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahseen H.","family":"Nasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milota","family":"Kaluzova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Kallay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes C.","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Izar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Burnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taukir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Switchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Ionascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Medvedovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.10.025_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11910-017-0741-2","article-title":"Targeted treatment of brain metastases","volume":"17","author":"Shonka","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/annonc\/mdw641","article-title":"Vemurafenib in metastatic melanoma patients with brain metastases: An open-label, single-arm, phase 2, multicentre study","volume":"28","author":"McArthur","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib5","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0140-6736(12)60398-5","article-title":"Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: A phase 1 dose-escalation trial","volume":"379","author":"Falchook","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S1470-2045(12)70431-X","article-title":"Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): A multicentre, open-label, phase 2 trial","volume":"13","author":"Long","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): A multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/annonc\/mdu049","article-title":"Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition","volume":"25","author":"Turajlic","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/EDBK_200819","article-title":"New era in the management of melanoma brain metastases","volume":"38","author":"Tawbi","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib13","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib15","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMoa1709684","article-title":"Overall survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"377","author":"Wolchok","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib16","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib18","unstructured":"Cook JM, Zhou H, Huang S, et\u00a0al. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects. US Patent 7119196 B2.\u00a02006."},{"key":"10.1016\/j.ijrobp.2020.10.025_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: Ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib21","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/nprot.2013.099","article-title":"Count-based differential expression analysis of RNA sequencing data using R and Bioconductor","volume":"8","author":"Anders","year":"2013","journal-title":"Nat Protocols"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc B"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib23","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: New perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","article-title":"Benchmark and integration of resources for the estimation of human transcription factor activities","volume":"29","author":"Garcia-Alonso","year":"2019","journal-title":"Genome Res"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.immuni.2015.12.006","article-title":"Compendium of immune signatures identifies conserved and species-specific biology in response to inflammation","volume":"44","author":"Godec","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib26","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide\u00a0expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib27","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib28","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib29","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib31","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2174\/092986707782360097","article-title":"An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: Correlation with comparative models","volume":"14","author":"Clayton","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib32","article-title":"A review of the updated pharmacophore for the alpha 5 gaba(a) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int J Med Chem"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11060-019-03115-0","article-title":"Modulating native GABAA receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death","volume":"142","author":"Kallay","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00401-013-1205-7","article-title":"\u03b15-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth","volume":"127","author":"Sengupta","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib35","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1166\/jbn.2016.2262","article-title":"First in vivo testing of compounds targeting Group 3 medulloblastoma using an implantable microdevice as a new paradigm for drug development","volume":"12","author":"Jonas","year":"2016","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1124\/jpet.104.080275","article-title":"Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys","volume":"313","author":"Platt","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.20121439","article-title":"p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis","volume":"210","author":"Matin","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2174\/13892029113146660011","article-title":"Tumor protein p63\/microRNA network in epithelial cancer cells","volume":"14","author":"Ratovitski","year":"2013","journal-title":"Current Genomics"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib40","doi-asserted-by":"crossref","first-page":"29146","DOI":"10.18632\/oncotarget.25635","article-title":"Regulation of the interferon-gamma (IFN-\u03b3) pathway by p63 and \u0394133p53 isoform in different breast cancer subtypes","volume":"9","author":"Mehta","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib41","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nature09459","article-title":"TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs","volume":"467","author":"Su","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042959","article-title":"Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes","volume":"7","author":"Mendu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib43","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1038\/s41467-018-06487-5","article-title":"GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections","volume":"9","author":"Kim","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00726-011-1193-7","article-title":"GABA is an effective immunomodulatory molecule","volume":"45","author":"Jin","year":"2013","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/PPO.0000000000000369","article-title":"Repurposing drugs for cancer radiotherapy: Early successes and emerging opportunities","volume":"25","author":"Khan","year":"2019","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/clpt.1992.123","article-title":"Pharmacokinetics and pharmacodynamics of oral diazepam: Effect of dose, plasma concentration, and time","volume":"52","author":"Friedman","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/acer.14000","article-title":"GABAa receptor subtypes and the abuse-related effects of ethanol in rhesus monkeys: Experiments with selective positive allosteric modulators","volume":"43","author":"Berro","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib48","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2020.10.025_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620344412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620344412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:55:46Z","timestamp":1759744546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620344412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0360301620344412"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.025","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma Cell Intrinsic GABAA Receptor Enhancement Potentiates Radiation and Immune Checkpoint Inhibitor Response by Promoting Direct and T Cell-Mediated Antitumor Activity","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}